Ticker

Profitability This table compares NKGen Biotech and SQZ Biotechnologies' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets NKGen Biotech N/A N/A -479.36% SQZ Biotechnologies -369.96% -119.83% -59.90% Valuation and Earnings This table compares NKGen Biotech and SQZ Biotechnologies"s revenue, earnings per share and valuation. Gross Revenue

Profitability This table compares SQZ Biotechnologies and NKGen Biotech's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets SQZ Biotechnologies -369.96% -119.83% -59.90% NKGen Biotech N/A N/A -479.36% Valuation and Earnings This table compares SQZ Biotechnologies and NKGen Biotech"s top-line revenue, earnings per share (EPS) and valuation.

Dr. Miller's appointment further enhances NKGen's scientific and clinical advisory capabilities as the Company advances its research in Alzheimer's and other related neurodegenerative diseases Dr. Miller's appointment further enhances NKGen's scientific and clinical advisory capabilities as the Company advances its research in Alzheimer's and other related neurodegenerative diseases

Profitability This table compares Genocea Biosciences and NKGen Biotech's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Genocea Biosciences N/A -182.88% -62.76% NKGen Biotech N/A N/A -479.36% Insider and Institutional Ownership 0.6% of Genocea Biosciences shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech